Advertisement
YOU ARE HERE: LAT HomeCollectionsVaccines
IN THE NEWS

Vaccines

ENTERTAINMENT
July 16, 2013 | By Meredith Blake
NEW YORK - Less than a week after Elisabeth Hasselbeck said her goodbyes after 10 years on "The View," another divisive blond has joined the daytime talk show. On Monday, Barbara Walters confirmed the rumors that Playboy model-turned-anti-vaccine-crusader Jenny McCarthy would officially become a co-host on "The View" when it launches its 17th season on Sept. 9. "We love her because she's fun and uninhibited and opinionated enough to help us begin the latest chapter in 'The View' history," Walters said on the air of McCarthy, who has made 17 appearances on the show, including eight as a guest co-host.
Advertisement
SCIENCE
June 28, 2013 | By Brad Balukjian
A "reverse vaccine" that allows people with Type 1 diabetes to produce their own insulin has passed its first test with human subjects, according to a new study. The success points to a potential new strategy for treating those in the early stages of the disease, experts said. The therapy is designed to protect cells in the pancreas that make insulin, a hormone the body needs to convert sugars and starches into energy. In people with Type 1 diabetes, the immune system goes haywire and attacks those crucial insulin-producing cells for reasons that medical researchers don't understand.
CALIFORNIA | LOCAL
June 21, 2013 | By Titania Kumeh, Los Angeles Times
Wade Gong's sister was 28 when she first felt a deep pain near the side of her stomach. Then she noticed the lump. The Chinese immigrant was uninsured, so she didn't go to the hospital right away. When she finally did, it was too late. She was in the late stages of liver cancer caused by hepatitis B, a silent virus that had been assaulting her liver since she was born. An Amherst graduate and math whiz who lived with her brother and parents in Rosemead, she died six months after being diagnosed.
SCIENCE
June 19, 2013 | By Karen Kaplan
The HPV vaccine may be controversial, but it works, new research shows. The rate of HPV infection among teenage girls dropped from 11.5% in the “pre-vaccine era” to 5.1% in the “vaccine era,” researchers from the Centers for Disease Control and Prevention reported Wednesday in the Journal of Infectious Diseases. That's a drop of 56%, the study notes. The infection rates cover the four types of HPV that are targeted by the vaccines Gardasil and Cervarix. Human papillomaviruses are the most common cause of sexually transmitted infections, and more than half of people who are sexually active become infected with one of the more than 40 types of HPV that are known to spread during vaginal, oral or anal sex, according to the National Cancer Institute . HPVs are responsible for nearly all cases of cervical cancer, along with most cases of anal cancer, the NCI says.
SCIENCE
April 26, 2013 | Melissa Healy
In another major setback for efforts to develop an HIV vaccine, federal researchers have shut down a key clinical trial after an independent panel of safety experts determined that volunteers who got an experimental vaccine appeared to be slightly more likely to contract the human immunodeficiency virus than those who got a placebo. Investigators involved in recruiting volunteers and running the trial at 21 sites across the country were ordered Tuesday morning to stop immunizing volunteers with the genetically engineered HVTN 505 vaccine and to inform the nearly 2,500 people who participated in the study whether they got the vaccine or the placebo.
SCIENCE
April 25, 2013 | By Melissa Healy, This post has been corrected, as indicated below.
In another major setback for efforts to develop a vaccine to boost immunity to the human immunodeficiency virus, known as HIV, a key clinical trial was ordered shut down this week after an independent panel of safety experts found that participants getting the vaccine appeared to be slightly more likely to contract the virus and no better at suppressing its replication than those who got a placebo. Investigators involved in recruiting volunteers and running the trial at 21 sites across the country, including the AIDS Research Alliance of America in Los Angeles, were ordered to stop immunizing volunteers with the genetically engineered HVTN 505 vaccine and to inform the subjects enrolled in the study whether they got the experimental vaccine or the placebo.
CALIFORNIA | LOCAL
April 22, 2013
Hilary Koprowski, a Polish-born researcher who developed the first successful oral vaccine for polio, has died. He was 96. Koprowski died of pneumonia April 11 at his Philadelphia home, said his son, Dr. Christopher Koprowski, a radiation oncologist. In 1950, Hilary Koprowski showed that it was possible to use his live-virus oral vaccine against polio, which had plagued the United States and other countries for decades. Another researcher, Dr. Albert Sabin, would win the race to get an oral vaccine licensed in the U.S. while Jonas Salk would develop an injectable vaccine that eliminated much of the disease in the country.
CALIFORNIA | LOCAL
April 18, 2013 | Ari Bloomekatz
Los Angeles County health officials on Wednesday began offering free meningitis vaccinations to low-income and uninsured residents while downplaying fears about a potential outbreak of the disease. "We really sympathize with the heightened concern related to meningococcal disease," said Dr. Jonathan Fielding, the county's top health officer. "We hope that by sharing what we know, we'll alleviate some of the anxiety that has surfaced over the last several days. " Fielding held a news conference only days after the sudden death of Brett Shaad, a 33-year-old West Hollywood lawyer who was diagnosed with the disease.
CALIFORNIA | LOCAL
April 15, 2013 | By Anna Gorman
Dozens of men lined up Monday morning at an AIDS Healthcare Foundation pharmacy in West Hollywood to get a free meningitis vaccine, days after a local man died from the disease. Allen Smith, a 21-year-old dance student, said he had a weak immune system and wanted to make sure that he was vaccinated to protect himself from the disease. After hearing about the death of Brett Shaad, a young lawyer who had contracted meningitis, Smith said he didn't want to take any chances. "It reminded everyone how short life really is," Smith said as he waited for the shot.
Los Angeles Times Articles
|